methyl 5-aminolevulinate has been researched along with Brill-Symmers Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben Brahim, E; Ben Lagha, I; Ben Tanfous, A; Chaabani, M; Fenniche, S; Hammami-Ghorbel, H; Koubaa, W; Zaouak, A | 1 |
1 other study(ies) available for methyl 5-aminolevulinate and Brill-Symmers Disease
| Article | Year |
|---|---|
Contribution of conventional photodynamic therapy in the treatment of primary cutaneous follicle center lymphoma.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Back; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Radiotherapy; Skin; Skin Neoplasms; Treatment Outcome | 2020 |